Loa loa Microfilarial Periodicity in Ivermectin-Treated Patients: Comparison Between Those Developing and Those Free of Serious Adverse Events

被引:27
作者
Kamgno, Joseph [1 ]
Pion, Sebastien D. [2 ]
Mackenzie, Charles D. [3 ]
Thylefors, Bjoern [4 ]
Boussinesq, Michel [2 ]
机构
[1] Univ Yaounde I, Filariasis Res Ctr, Yaounde, Cameroon
[2] Inst Rech Dev, UMR 145, F-34394 Montpellier 5, France
[3] Michigan State Univ, Filarial Dis Unit, E Lansing, MI 48824 USA
[4] Mectizan Donat Program, Decatur, GA 30030 USA
关键词
ONCHOCERCA-VOLVULUS MICROFILARIAE; WUCHERERIA-BANCROFTI; DIROFILARIA-IMMITIS; DIETHYLCARBAMAZINE; ENCEPHALITIS; INFECTION; EFFICACY; LOIASIS; TRIAL; AREA;
D O I
10.4269/ajtmh.2009.09-0356
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The main risk factor of post-ivermectin serious adverse events (SAEs) is the presence of a high Loa loa microfilaremia. However, the majority of patients with such high loads do not develop SAEs, suggesting that co-factors may be involved. An infection with simian Loa parasites, whose microfilariae show a nocturnal periodicity, might be such a co-factor. The periodicity of Loa microfilariae was compared, using cosinor methodology, in 4 patients who had developed a post-ivermectin neurologic SAE, 4 patients who had experienced a non-neurologic SAE, and 14 control individuals. The periodicity was similar in all three groups, with a peak of microfilaremia occurring between 12:30 and 2:00 PM. The results of this study, which for the first time characterizes the periodicity of Loa microfilariae mathematically, suggest that post-ivermectin SAEs are not related to an infection with a Loa simian strain.
引用
收藏
页码:1056 / 1061
页数:6
相关论文
共 54 条
[1]   Microfilarial periodicity of Wuchereria bancrofti in Vanuatu [J].
Abe, M ;
Yaviong, J ;
Taleo, G ;
Ichimori, K .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2003, 97 (05) :498-500
[2]  
AIKAT TK, 1977, INDIAN J MED RES, V65, P58
[3]   THE CHEMOTHERAPY OF ONCHOCERCIASIS .10. AN ASSESSMENT OF 4 SINGLE DOSE TREATMENT REGIMES OF MK-933 (IVERMECTIN) IN HUMAN ONCHOCERCIASIS [J].
AWADZI, K ;
DADZIE, KY ;
SHULZKEY, H ;
HADDOCK, DRW ;
GILLES, HM ;
AZIZ, MA .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 1985, 79 (01) :63-78
[4]  
Awadzi K, 1997, ANN TROP MED PARASIT, V91, P281, DOI 10.1080/00034989761139
[5]  
BASSET D, 1989, PATHOL BIOL, V37, P668
[6]   Circadian pattern of cercarial emergence in Schistosoma mansoni (Platyhelminthes: Digenea) from isolated Biomphalaria glabrata [J].
Bogea, T ;
Favre, TC ;
Rotenberg, L ;
Silva, HS ;
Pieri, OS .
CHRONOBIOLOGY INTERNATIONAL, 1996, 13 (02) :93-101
[7]   Three probable cases of Loa Loa encephalopathy following ivermectin treatment for onchocerciasis [J].
Boussinesq, M ;
Gardon, J ;
Gardon-Wendel, N ;
Kamgno, J ;
Ngoumou, P ;
Chippaux, JP .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 58 (04) :461-469
[8]   Relationships between the prevalence and intensity of Loa loa infection in the Central province of Cameroon [J].
Boussinesq, M ;
Gardon, J ;
Kamgno, J ;
Pion, SDS ;
Gardon-Wendel, N ;
Chippaux, JP .
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY, 2001, 95 (05) :495-507
[9]   5 CASES OF ENCEPHALITIS DURING TREATMENT OF LOIASIS WITH DIETHYLCARBAMAZINE [J].
CARME, B ;
BOULESTEIX, J ;
BOUTES, H ;
PURUEHNCE, MF .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1991, 44 (06) :684-690
[10]  
CARME B, 1983, ANN SOC BELG MED TR, V63, P333